BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1530921)

  • 1. Hierarchy of responsiveness in vivo and in vitro among T cells expressing distinct Mls-1a-reactive v beta domains.
    Waanders GA; McDonald HR
    Eur J Immunol; 1992 Jan; 22(1):291-3. PubMed ID: 1530921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two separate mechanisms of T cell clonal anergy to Mls-1.
    Yui K; Ishida Y; Katsumata M; Komori S; Chused TM; Abe R
    J Immunol; 1993 Dec; 151(11):6062-75. PubMed ID: 8245451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells.
    Arase-Fukushi N; Arase H; Ogasawara K; Good RA; Onoé K
    J Immunol; 1993 Nov; 151(9):4445-54. PubMed ID: 8104995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic epithelium induces neither clonal deletion nor anergy to Mls 1a antigens.
    Bandeira A; Coutinho A; Burlen-Defranoux O; Khazaal I; Coltey M; Jacquemart F; Le Douarin N; Salaün J
    Eur J Immunol; 1992 Jun; 22(6):1397-404. PubMed ID: 1534756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of clonal deletion varies with tolerizing antigen.
    Schneider R; Pircher H; Speiser DE; Zinkernagel R; Hengartner H
    Thymus; 1992 Aug; 20(1):5-15. PubMed ID: 1387745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
    Anderson GD; Banerjee S; Luthra HS; David CS
    J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superantigen-driven peripheral deletion of T cells. Apoptosis occurs in cells that have lost the alpha/beta T cell receptor.
    Huang L; Crispe IN
    J Immunol; 1993 Aug; 151(4):1844-51. PubMed ID: 8345186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
    Tucek CL; Desaymard C; Papiernik M
    J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the T cell receptor alpha-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor beta-chain transgenic mice.
    Blackman MA; Smith HP; Le P; Woodland DL
    J Immunol; 1993 Jul; 151(2):556-65. PubMed ID: 8335899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
    Abe R; Foo-Phillips M; Granger LG; Kanagawa O
    J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
    MacNeil D; Fraga E; Singh B
    Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant induction of T cell tolerance in B cell suppressed mice.
    Gollob KJ; Palmer E
    J Immunol; 1993 May; 150(9):3705-12. PubMed ID: 8473728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of V beta 6+ T cells in Mls-1a mice. A role for the third complementarity-determining region (CDR3) of the T cell receptor beta chain in superantigen recognition.
    Chies JA; Marodon G; Joret AM; Regnault A; Lembezat MP; Rocha B; Freitas AA
    J Immunol; 1995 Nov; 155(9):4171-8. PubMed ID: 7594572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of class II molecules in Mls 1a recognition by CD4+ T cells is independent of the CD4 molecule.
    Borrero H; Collazo L; Macphail S
    Cell Immunol; 1993 Dec; 152(2):594-604. PubMed ID: 7903065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies.
    Gaugler B; Langlet C; Martin JM; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 1991 Oct; 21(10):2581-9. PubMed ID: 1680703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population movement and fate of autoreactive V beta 6+ T cells in Mls-1a mice.
    Hosono M; Ideyama S; Gyotoku J; Katsura Y
    Immunology; 1993 Jul; 79(3):391-7. PubMed ID: 8406567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A characteristic Mls-1a response precedes Mls-1a anergy in vivo.
    Dannecker G; Mecheri S; Staiano-Coico L; Hoffmann MK
    J Immunol; 1991 Apr; 146(7):2083-7. PubMed ID: 1826014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of an Mls-1a-like superantigen to BALB/c mice by foster-nursing on F1 Mls-1bxa mothers. Sex-influenced onset of clonal deletion.
    Piazzon I; Goldman A; Torello S; Nepomnaschy I; Deroche A; Dran G
    J Immunol; 1994 Aug; 153(4):1553-62. PubMed ID: 7913941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
    J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.